Physician profile
John C Dean
NPI 1083976419
$1,047.97
in general payments reported to CMS, 2019-2025
19 companies · $267 in 2025
The $267 reported for 2025 was more than what 82% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $44.54 · 2023: $236 · 2024: $374 · 2025: $267.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $877.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $137.45 | 2023-2024 | Jornay Pm |
| Glaxosmithkline, LLC. | $105.65 | 2019-2025 | Bexsero |
| Sobi, INC | $86.70 | 2020-2023 | |
| Pfizer INC. | $85.38 | 2023-2025 | |
| Sanofi Pasteur INC. | $76.04 | 2019-2024 | |
| Baxter Healthcare | $75.47 | 2024 | Hillrom - Carnation Ambulatory Monitor |
| Collegium Pharmaceutical, INC. | $70.89 | 2025 | Jornay Pm |
| Seqirus USA INC | $68.06 | 2023-2024 | Flucelvax, Flucelvax Quadrivalent |
| Organon LLC | $61.64 | 2025 | Nexplanon |
| Sanofi-Aventis U.S. LLC | $45.28 | 2024-2025 | |
| Merck Sharp & Dohme LLC | $42.04 | 2020-2025 | Gardasil 9, Enflonsia, M-M-R II |
| Corium, LLC | $39.86 | 2024 | Azstarys |
| Cranial Technologies, INC | $37.15 | 2024-2025 | Doc Band |
| Kaleo, INC. | $24.90 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $22.36 | 2024 | Flumist Quadrivalent |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $22.05 | 2025 | Slynd |
| Avion Pharmaceuticals | $17.66 | 2023 | Methylphenidate Hydrochloride |
| Vertical Pharmaceuticals, LLC | $16.63 | 2020 | |
| Nestle Healthcare Nutrition INC. | $12.76 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Dean listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.